S Korean drug firm SK Bioscience targets IPO in first half of 2021

S Korean drug firm SK Bioscience targets IPO in first half of 2021

South Korean drug company SK Bioscience aims to seek a domestic stock market listing in the first half of next year, it said on Friday.